NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 112 filers reported holding NEVRO CORP in Q2 2015. The put-call ratio across all filers is 2.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,536,000 | -30.6% | 89,953 | -0.3% | 0.01% | -33.3% |
| Q3 2016 | $9,415,000 | +42.4% | 90,194 | +0.6% | 0.01% | +50.0% |
| Q2 2016 | $6,612,000 | +105.5% | 89,639 | +56.7% | 0.01% | +100.0% |
| Q1 2016 | $3,218,000 | -14.9% | 57,199 | +2.1% | 0.00% | -20.0% |
| Q4 2015 | $3,781,000 | +45.6% | 56,000 | +0.0% | 0.01% | +25.0% |
| Q3 2015 | $2,597,000 | -5.9% | 55,978 | +9.0% | 0.00% | +33.3% |
| Q2 2015 | $2,760,000 | +139.8% | 51,356 | +113.8% | 0.00% | +50.0% |
| Q1 2015 | $1,151,000 | -22.1% | 24,022 | -37.1% | 0.00% | 0.0% |
| Q4 2014 | $1,477,000 | – | 38,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |